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Increasing evidence links chronically elevated glucocorticoid
levels and cognitive impairments in a subpopulation of aged
rodents and humans. Antidepressant drugs improve
hypothalamic-pituitary-adrenal axis feedback regulation and
reduce plasma glucocorticoid levels. Decreasing the cumula-
tive lifetime exposure to glucocorticoid excess by long-term
exposure to antidepressants may prevent the emergence of
cognitive impairments in aged rats. To test this hypothesis, we
treated middle-aged male Lister hooded rats (16 months) with
amitriptyline until they were 24 months of age, and their cog-
nitive function was assessed in the water maze. Performance in
the spatial learning task declined significantly with aging ( p 
0.01), with 33% of aged controls showing poorer (2.5 SD)
probe test performance than young controls. Amitriptyline
treatment from midlife preserved water maze performance with
aging ( p  0.01 compared with aged controls) and significantly
( p  0.01) reduced the proportion of poor performers (7%).
Measures of anxiety-related behaviors in the elevated plus-
maze were significantly ( p  0.05) decreased in the aged rats
after amitriptyline. Furthermore, evening plasma corticosterone
levels were reduced (30% decrease; p  0.01 compared with
aged controls) after 6 months of amitriptyline. These data sug-
gest that long-term treatment with amitriptyline decreases the
prevalence of cognitive impairment in aged rats and that this
may, in part, be a consequence of reduced plasma corticoste-
rone levels and reduced anxiety.
Key words: corticosterone; water maze; spatial learning; am-
itriptyline; anxiety; glucocorticoid
Consistent evidence has revealed that approximately one-third of
aging rats show an association between memory impairments,
pathological changes in hippocampal neurons, and elevated blood
levels of glucocorticoid hormones (corticosterone in rats, cortisol
in humans) (Issa et al., 1990; Yau et al., 1995). The latter appears
to be attributable to insensitivity to glucocorticoid negative feed-
back control of the hypothalamic-pituitary-adrenal (HPA) axis.
Glucocorticoid-mediated negative feedback sensitivity is thought
to be related to loss of glucocorticoid receptors (GRs) in the
brain, particularly in the hippocampus (Jacobson and Sapolsky,
1991). From a mechanistic point of view, chronic glucocorticoid
excess interferes with long-term potentiation as well as other
putative electrophysiological processes related to learning and
memory (Diamond et al., 1992; Pavlides et al., 1993); it also
adversely affects hippocampal neuronal structure and eventually,
perhaps, neuronal survival (Sapolsky, 1996). Glucocorticoids ap-
pear to be causal, because manipulations that keep glucocorticoid
levels low throughout life prevent the emergence with age of
memory impairments and hippocampal neuronal damage (Land-
field et al., 1981; Meaney et al., 1988). In elderly humans, a link
has also been established between elevated plasma cortisol levels,
hippocampal atrophy, and the development of cognitive impair-
ments (Lupien et al., 1998), underscoring an important clinical
component of chronic glucocorticoid excess.
A critical target for manipulating blood glucocorticoid levels is
GR density in brain regions involved in negative feedback control
of circulating hormone levels. The hippocampus is of prominent
importance, because changes in GR density in this region have
been associated with altered plasma glucocorticoid levels
(Meaney et al., 1989; Jacobson and Sapolsky, 1991). There are
two types of receptors for glucocorticoids in the hippocampus:
the mineralocorticoid receptor (MR) and the GR; both are mem-
bers of the nuclear hormone receptor superfamily, and both are
involved in glucocorticoid feedback (De Kloet, 1991). Recent
studies have shown the key importance of monoaminergic neu-
rotransmitters, particularly serotonin [5-hydroxytryptamine (5-
HT)] and norepinephrine (NE), in the maintenance and regula-
tion of GR and MR expression in the hippocampus (Seckl et al.,
1998). Antidepressant drugs, which alter monoaminergic neuro-
transmission, increase hippocampal GR and MR expression
(Seckl and Fink, 1992) and indeed normalize HPA function in
depression, even before clinical improvement occurs (Holsboer
and Barden, 1996). We have shown that antidepressants decrease
glucocorticoid levels and improve HPA feedback control in aged,
cognitively impaired rats (Yau et al., 1995; Rowe et al., 1997).
In our previous studies, however, although administration of
the tricyclic antidepressant amitriptyline for 2 months facilitated
hippocampal (spatial) learning and memory in young rats, this
treatment failed to improve memory or prevent deficits in cogni-
tion in already aged (24- to 26-month-old) rats (Yau et al., 1995).
This lack of efficacy might have been attributable to a loss of
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plasticity of an already subtly impaired brain. In the present study,
we treated rats with amitriptyline for 8 months from middle age
(16 months) and tested their performance in a spatial learning
water maze task after 2 months of treatment (to compare with our
previous work) and after 8 months of treatment when the rats
were 24 months of age. Anxiety-like behaviors were also assessed
in the elevated plus-maze at 24 months.
MATERIALS AND METHODS
Animals. Male Lister hooded rats (Charles River, Kent, UK) were
obtained at 3 months of age and maintained undisturbed before com-
mencing the study. Rats were housed three per cage under conditions of
controlled lighting (lights on from 7:00 A.M. to 7:00 P.M.) and temper-
ature (22°C), with access to food (Clark’s rodents maintenance diet
cubed; Special Diet Services, Essex, UK) and tap water ad libitum.
Animals with overt signs of respiratory distress, infection, or tumors were
excluded. All procedures were performed in strict accordance with the
United Kingdom Animals (Scientific Procedures) Act.
Antidepressant drug administration. Rats were 16 months of age when
randomly assigned to oral treatment with amitriptyline (Sigma, St. Louis,
MO) via their drinking water for 8 months. Controls received tap water.
Drinking bottles were light-protected, and solutions were renewed on
alternate days. Drug intake and animal weight were monitored on a
weekly basis. Control rats drank 26.8  0.3 ml/d, and amitriptyline-
treated rats drank 23  0.6 ml/d. The average dose of amitriptyline
consumed was 8.2  0.2 mg  kg1  d1, which is comparable with
previously reported doses that alter HPA axis function (Reul et al., 1993;
Yau et al., 1995).
Behavioral testing. The spatial memory performances of the aged rats
were assessed in the water maze after 2 months and finally after 8 months
of amitriptyline treatment. Young controls (6 months of age) were also
tested in the water maze twice, 2 months apart, for comparison.
Rats were trained in a 1.8-m-diameter open-field water maze filled
with water (26°C) and made opaque with latex liquid (Yau et al., 1995).
Prominent extra-maze visual cues around the room remained in fixed
positions throughout the experiment. During behavioral testing, animals
were required to locate a hidden submerged platform 10 cm in diameter
(1.5 cm below the surface), which remained in the same position across
trials for individual animals but was counterbalanced across animals.
Four equally spaced points (north, south, east, and west) around the edge
of the pool were used as starting positions. The animals were given four
trials per day for 4 d. Trials began with the rat placed in the pool facing
the side wall at a start position and ended once the animal had found the
platform; if the rat had not found the platform within 120 sec, it was
guided there by hand. After a period of 30 sec on the platform, the rat
was immediately re-placed in the pool at a different start position for the
next trial. The latency and swim paths of the rats were monitored by a
video camera mounted in the ceiling and by a computerized tracking
system [HVS image analyzer (HVS Image, Hampton, UK) and Acorn
Archimedes computer (Acorn Computer Group, Cambridge, UK)]. On
day 5, rats were given a retention (probe) test. For this, the platform was
removed, and the swim path and time spent in the platform (“training”)
quadrant were recorded over 60 sec.
Elevated plus-maze. The elevated plus-maze (Panlab, Barcelona,
Spain) was a cross-shaped platform made of black plastic. The apparatus
consisted of two opposing open arms (50  10 cm) and two arms of the
same size but enclosed by walls 40 cm high. A central area of 10 cm 2
connected all four arms. The maze was elevated 64 cm from the floor. At
the start of the test, a rat was placed in the central area facing one of the
open arms and allowed to explore the maze freely for 5 min. During this
period, the number of open-arm and closed-arm entries and the time
spent on open arms and closed arms were measured. The apparatus was
wiped clean with ethanol between rats.
Blood sampling. Blood samples (300 l) for determination of basal
plasma corticosterone levels were taken within 30 sec of a tail nick at 1 hr
into the light (8:00 A.M., morning sample) or dark (8:00 P.M., evening
sample) phase. To avoid multiple sampling in any one animal, tail-nick
blood sampling from an equal number of rats randomly selected from
each group was performed either 3 or 6 months after antidepressant
treatment had been initiated. Blood samples were taken into EDTA-
coated Eppendorf tubes, placed on ice, centrifuged, and stored at20°C.
Plasma corticosterone levels were measured by a previously described
radioimmunoassay (Al Dujaili et al., 1981), modified for microtiter plate
scintillation proximity assay (Amersham Biosciences, Little Chalfont,
UK) with a highly specific antiserum (Dr. C. Kenyon, Edinburgh Uni-
versity) and [ 3H]corticosterone (Amersham Biosciences). The intra-
assay and interassay coefficients of variation were 9.4% and 9.2%,
respectively.
Statistical analysis. Only data from rats that completed the full exper-
imental protocol were assessed. Data were assessed by ANOVA followed
by the Scheffe´ post hoc test. Frequency distribution was assessed by the  2
test. Significance was set at a value of p 0.05. Values are means SEM.
RESULTS
Antidepressant effects on cognitive performance
The aged rats were tested in the water maze initially at 18 months
of age after 2 months of amitriptyline treatment and again at 24
months of age after 8 months of amitriptyline. All young and
18-month-old rats were able to learn the hidden-platform task
efficiently, showing a decrease in escape latency with days of
training (young, F(11,36)  12.0; aged controls, F(22,69)  49.4;
aged amitriptyline-treated, F(10,33)  37.0; all p  0.001) (Fig. 1).
Young rats (6 months of age) showed a lower mean escape latency
on the first day of training than aged rats ( p  0.05) but did not
differ on the other days of training; all groups achieved a similar
escape nadir (20 sec) after 4 d of training (Fig. 1). At 18 months
of age, amitriptyline treatment for 2 months had no effect on
mean escape latency. Young rats given amitriptyline show im-
proved spatial memory retention as measured in the “probe test”
(percentage of time spent in the training quadrant) but not
improved acquisition, as determined by escape latency (Yau et al.,
1995). However, probe test times in 18-month-old rats after 2
months of amitriptyline treatment were similar to both water-
treated 18-month-old and young controls (young 6-month-old
controls, 41.6  4%; 18-month-old controls, 42.9  2.0%; 18-
month-old amitriptyline-treated, 46.2  2.6%).
When the rats were 24 months of age (after 8 months of
amitriptyline or water alone), they were retested in the water
maze together with the young controls (8 months of age). The
aged rats continued to show learning, with a decrease in mean
escape latency across the first 2 d of training (water controls,
F(34,105)  6.57, p  0.001; amitriptyline-treated, F(28,87)  14,
p  0.001). Indeed, the mean escape latency on the last day of
training was not significantly different from that of the young
controls. Amitriptyline did not significantly alter the overall es-
cape latency in the aged rats compared with aged controls ( p 
0.2) (Fig. 1). The average swim speeds were comparable for both
Figure 1. Water maze performance to find a hidden platform across days
during the acquisition stage initially after 2 months of amitriptyline
treatment and then again 6 months later after 8 months of amitriptyline
treatment. Probe tests were given on days 5 and 10 of testing. Young
controls at 6 months of age were included for comparison. Values are the
mean  SEM of the mean escape latency of four trials per day. Numbers
of rats are in parentheses.
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aged rat treatment groups (controls, 19  0.5 cm/sec; amitripty-
line, 19  0.8 cm/sec), whereas the young control rats were
significantly faster (24  0.6 cm/sec; p  0.001 compared with
aged controls).
Decreased escape latencies across a series of training trials are
not necessarily an indication of spatial learning, because these
measures do not provide information about search strategy (Gal-
lagher et al., 1993). For example, some aged rats use a circling
strategy, which is less efficient than learning the position of the
platform but can support a better escape latency performance
than a random search. Therefore, we used probe test percentage
times, which are also less dependent on swim speed, to rank the
final water maze learning performances of the aged rats. The
probe test performances in the aged rats showed a large variation
(Fig. 2A), but the overall pattern was that cognitive function
decreased with aging (28% decrease in probe test time in training
quadrant; p  0.01 compared with young controls) (Fig. 2B).
Note that the aged cognitively impaired rats showed 8.6  2.2%
thigmotaxic behavior (percentage of time spent near side walls),
similar to that of the aged cognitively unimpaired rats (10.4 
2.3%).
All of the aged rats were ranked according to their final probe
test times and classed as poor performers if probe times were
31%, which is 2.5 SD below the mean for a large cohort of
young rats in this task in our water maze (25% represents
chance). Note that all of the contemporaneous young animals
performed within this limit in this study. The proportion of poor
performers among aged rats was 33% in controls and 7% in
amitriptyline-treated rats ( p  0.01) (Fig. 2A). The aged cogni-
tively impaired control rats (probe test percentage times of
31%) had swim speeds similar to those of the aged cognitively
unimpaired rats (swim speeds: impaired, 19.3  0.8 cm/sec;
unimpaired, 18.5  0.6 cm/sec), suggesting that sensorimotor
differences do not underpin the variation with aging. Amitripty-
line treatment significantly altered the distribution of water maze
learning abilities in the aged rats, such that the overall perfor-
mance (probe test time) was improved compared with aged
controls (25% increase; p  0.01) but did not differ significantly
from that of young controls (Fig. 2A,B). This was not a survival
effect, because there were equal numbers of age-related deaths in
each group (controls, 34%; amitriptyline-treated rats, 35%).
Corticosterone levels and adrenal weights
Plasma corticosterone levels at 21 months of age (water controls)
were significantly higher than those of young controls during both
the morning ( p  0.01) and evening ( p  0.001) phases of the
diurnal cycle (Fig. 3). This was reflected in the adrenal weights,
which were significantly increased ( p  0.01) in the aged rats
compared with young controls (Table 1). Amitriptyline treatment
decreased the adrenal weights ( p  0.05) but had no effect on
body weight (Table 1). Plasma corticosterone levels were not
significantly altered during the morning phase of the cycle after 3
or 6 months of amitriptyline treatment (Fig. 3). However, ami-
triptyline significantly decreased corticosterone levels during the
Figure 2. A, Learning performance of individual rats expressed as per-
centage of time spent in the training (target) quadrant during the final
probe test after 8 months of amitriptyline treatment. Rats were classed
with impaired performance if their probe test times were 31% (25%
represents chance). Using the 2 test to assess the distribution of perfor-
mances, there were fewer impaired rats in the amitriptyline-treated group
(7%, **p  0.01 compared with aged vehicle controls; 33%, *p  0.05
compared with young). The dashed line represents performance at the
31% probe test time level; any performances below this level were
classified as cognitively impaired. B, Final probe test after 8 months of
amitriptyline treatment showing the mean  SEM percentage of time
spent in the different quadrants. The young controls were 8 months of age;
aged rats were 24 months of age. *p 0.01 compared with young controls.
†p  0.01 compared with aged controls. old(W), Water-treated aged
controls; old(A), amitriptyline-treated aged rats.
Figure 3. Plasma corticosterone levels in rats at 8.00 A.M. (morning
trough) and 8.00 P.M. (evening peak) of the circadian cycle during
antidepressant treatment. Rats were 19 and 22 months of age after 3 and
6 months of antidepressant treatment, respectively. Plasma corticosterone
levels from young control rats 6 months of age were included for com-
parison. *p  0.01 compared with aged control rats. **p  0.05 compared
with young control rats. Numbers of rats with blood sampled are given in
parentheses.
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evening phase of the cycle after 3 months of treatment (26%
decrease; p  0.01 compared with vehicle controls), and this was
maintained after 6 months of treatment (30% decrease; p  0.01)
(Fig. 3).
Elevated plus-maze
There was no effect of age or amitriptyline treatment on locomo-
tion on the elevated plus-maze [number of open (F(2,28)  2.7;
p  0.08) and closed (F(2,28)  0.6; p  0.6) arm entries].
Amitriptyline significantly reduced “anxiety-associated” behav-
iors in the aged rats [increased time spent in the open arms (103%
increase; p  0.01 compared with aged controls), decreased time
spent in the closed arm (51% decrease; p  0.05 compared with
aged controls), and increased percentage of time spent in the
open arms (82% increase; F(2,28)  3.9; p  0.05 compared with
aged controls)] (Fig. 4). Age itself had no significant effect on the
percentage of time spent on the open arms ( p  0.13 compared
with young controls).
DISCUSSION
The present study suggests that the use of antidepressants may
serve as a useful therapeutic approach in attempting to amelio-
rate the occurrence of cognitive impairments among populations
of aged individuals (Meaney et al., 1988; Yau et al., 1995; Rowe
et al., 1997). An intervention paradigm such as chronic adminis-
tration of amitriptyline starting at midlife resulted in an overall
improvement in water maze performance and a significant reduc-
tion in the proportion of animals that normally would have shown
memory deficits at 24 months of age. This amitriptyline treatment
regimen also lowered plasma corticosterone levels and reduced
anxiety-related behaviors in the aged rats, suggesting a more
generalized improvement both in stress-related hormone levels
and in behavior.
Chronic amitriptyline treatment reduces evening
corticosterone levels and preserves spatial memory in
aged rats
Previous cross-sectional studies have suggested that elevated cor-
ticosterone levels occur in 30% of aged rats (Issa et al., 1990;
Yau et al., 1995; Rowe et al., 1997). Such animals are more likely
to exhibit cognitive impairments in the water maze task, whereas
aged rats with lower plasma corticosterone levels typically show
normal spatial learning. In fact, individual spatial memory per-
formance in aged rats correlates negatively with contemporane-
ous basal plasma corticosterone levels (Yau et al., 1995). It may be
argued that when treatment was started, the distribution of per-
formance of the rats in the treatment groups may not have been
equal. However, when morning and evening blood samples were
tested at 19 months of age, plasma corticosterone levels were not
significantly different from those of young controls. Moreover,
spatial learning did not differ at 14 months of age compared with
young controls (J. L. W. Yau and J. R. Seckl, unpublished obser-
vations), nor did it differ when rats were tested 2 months after
commencement of amitriptyline treatment at 18 months in the
present study. Therefore, all of the aged rats appeared to be
cognitively intact at the onset of treatment. In the aged controls,
plasma corticosterone levels became significantly elevated (in the
morning and in the evening) only later in life, at 22 months of age,
consistent with previous studies (Yau et al., 1995; Rowe et al.,
1997).
The lack of effect of amitriptyline on spatial memory perfor-
mance after 2 months of treatment is in contrast to our previous
finding that 2 months of amitriptyline treatment improved spatial
memory in young rats (Yau et al., 1995). This discrepancy may be
partly a result of the different route of drug administration (Yau
et al., 1995) and/or the different ages of the rats at the start of
treatment. The latter is an intriguing alternative, because it would
imply that the cognitive plasticity to amitriptyline seen in young
rats can also occur in middle-aged animals, but perhaps with a
slower onset. Consistent with our previous study (Yau et al.,
1995), evening corticosterone levels were selectively decreased
Figure 4. Effects of aging with or without amitriptyline administration
from middle age for 8 months on behavior in the elevated plus-maze
compared with young (6-month-old) controls. A, The number of entries to
open and closed arms was not significantly different between the groups.
B, The time spent in the open and closed arms differed (**p  0.05
compared with aged controls) after amitriptyline treatment. C, The per-
centage of time spent in the open arms [open/(open  closed)] was
increased after amitriptyline treatment; *p  0.05 compared with aged
controls. old (W), Water-treated aged 24-month-old controls; old (A),
amitriptyline-treated aged rats. Values are mean  SEM.
Table 1. Adrenal weight expressed as absolute weight of both adrenals
and relative to body weight in the antidepressant- and vehicle (water)-
treated 24-month-old rats
Adrenal
weight (mg)
Body
weight (gm)
Adrenal weight/
body weight
(mg/gm)
Vehicle (water) (32) 80.6  2.9* 523  12 0.16  0.01*
Amitriptyline (26) 70.7 3.0*† 507  15 0.14  0.01*
Young controls (15) 53.2  4.2 504  12 0.10  0.01
The numbers of rats per group are in parentheses. *p  0.01 compared with young
controls; †p  0.05 compared with aged controls. Values are means  SEM.
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after 3 months of amitriptyline treatment, and this decrease was
maintained after 6 months of treatment. This suggests that
chronic amitriptyline treatment lowers HPA activity. The unal-
tered basal HPA axis activity during the morning is consistent
with some (Reul et al., 1994; Yau et al., 1995; Rowe et al., 1997)
but not other (Reul et al., 1993) studies and may reflect differ-
ences among studies related to age, treatment duration, route of
administration, or strain. A plausible explanation for the lack of a
morning effect may arise from the finding that the evening phase,
or active phase of the diurnal rhythm, is believed to be the period
of enhanced brain drive, whereas the morning corticosterone
release may result from peripheral sources (Dallman et al., 1987).
Animals treated with corticotropin-releasing hormone (CRH)
antisera exhibit an attenuated evening peak in ACTH levels,
whereas morning levels remained undisturbed (Carnes et al.,
1989, 1990). This latter finding suggests that the source of the
morning signal is not necessarily dependent on a CRH signal;
however, central CRH is required for the evening rise in plasma
corticosterone levels.
HPA axis feedback, corticosterone levels, and
spatial memory
In cognitively impaired aged rats, stress-induced rises in plasma
corticosterone levels take longer to fall back to baseline than in
cognitively unimpaired aged rats or young rats, suggesting defects
in CNS feedback sensitivity (Issa et al., 1990). Middle-aged rats
treated with stress levels of corticosterone for 3 months showed
impaired learning in the water maze (Bodnoff et al., 1995). In
contrast, the performance of rats in the water maze was improved
by administration of corticosterone immediately after training
(Sandi et al., 1997). Therefore, it appears that in certain circum-
stances, a transient increase in plasma corticosterone levels in-
duced by training may facilitate memory processing (Sandi et al.,
1997), but that longer durations or chronically elevated cortico-
sterone levels often associated with aging (and reflecting poor
HPA-negative feedback regulation) (Issa et al., 1990) may impair
memory (Bodnoff et al., 1995). The present results suggest that
amitriptyline improves glucocorticoid negative feedback efficacy
in aged rats, as reflected in the reduced evening corticosterone
levels. This is consistent with our previous finding, in which
chronic desipramine treatment enhanced glucocorticoid-induced
negative feedback efficacy and restored basal plasma corticoste-
rone levels in aged cognitively impaired rats (Rowe et al., 1997).
An enhanced glucocorticoid negative feedback efficacy may sup-
press water maze training-induced increases in plasma cortico-
sterone levels more efficiently, such that plasma corticosterone
levels do not remain high for longer than necessary to facilitate
memory.
Interestingly, chronic amitriptyline treatment altered a specific
aspect of water maze learning in the aged rats. The escape latency
to find the hidden platform, thought to reflect the consolidation of
spatial information via GRs (Oitzl and de Kloet, 1992), was
unchanged. Furthermore, aged controls and amitriptyline-treated
aged rats both had approximately equivalent declines in perfor-
mance over the 6 month interval from initial testing in the water
maze. This suggests that long-term memory does not appear to be
preserved by amitriptyline treatment. In contrast, the search–
escape strategies during the probe trial, thought to be more
reflective of the actions of the MR (Oitzl and de Kloet, 1992),
were enhanced in amitriptyline-treated aged rats. Together, this
suggests that amitriptyline treatment may induce changes in hip-
pocampal MR to alter the probe test times without affecting
escape latencies. Previous studies have indeed shown that anti-
depressants, including amitriptyline, induce a more prominent
effect on increasing hippocampal MR than GR expression and
that the magnitude of this increase is dependent on treatment
duration (Reul et al., 1993, 1994; Yau et al., 1995). Moreover,
several studies suggest that it is the MR in the hippocampus
(rather than the GR) that shows the more robust decline with
aging (van Eekelen et al., 1991; Rothuizen et al., 1993; Hassan et
al., 1999).
Antidepressant effects on monoaminergic systems
The mechanisms underlying the effects of long-term amitriptyline
on water maze learning remain to be fully elucidated. The pro-
cess may be glucocorticoid-mediated, or it may occur via the NE
or the 5-HT system or a combination of several of these systems.
Reversal learning slows down with age, a change related to
age-associated changes in monoaminergic systems (Tanaka et al.,
1992). Activation of the NE system in the basolateral amygdala
appears to be an essential step in mediating glucocorticoid effects
on memory storage (Quirarte et al., 1997) and in inducing
glucocorticoid-mediated plasticity in the hippocampus. This sug-
gests that successful long-term antidepressant therapy regimes
may require more recruitment of NE-related systems. This con-
tention is supported by recent preliminary findings that long-term
treatment with desipramine (a selective NE-reuptake inhibitor)
may also eliminate the emergence of cognitive deficits in a cohort
of aged rats (Rowe et al., 1998), whereas venlafaxine, which has
a greater potency for 5-HT reuptake than NE reuptake (Beique
et al., 1998; Redrobe et al., 1998), had no significant effect on
spatial learning in aged rats (Yau and Seckl, unpublished obser-
vations). Amitriptyline, in contrast, is approximately equally ac-
tive as an inhibitor of 5-HT reuptake and NE reuptake (Meltzer
and Lowy, 1997).
Anxiolytic effects of amitriptyline
Differences in anxiety-related behaviors could have a secondary
effect on the rate of learning (reflecting an effect akin to
pseudodementia in humans). Increased fearfulness or sensorimo-
tor disturbances may cause performance impairments in the
water maze that can sometimes be misinterpreted as spatial
memory deficits (Miyakawa et al., 1996; Cain, 1997). Pretraining
of animals in the water maze has been shown to reduce the
general (nonspatial) aspects of solving the task (Cain, 1997). In
the present study, the extensive training given (twice tested in
water maze) most likely would have reduced the nonspatial aspect
of learning the water maze task by the stage when all rats were
finally retested. Furthermore, the aged cognitively impaired rats
had swim speeds and thigmotaxic behavior (indicative of fearful-
ness) that were not significantly different from those of the aged
cognitively unimpaired rats. Thus, the learning impairments
found in this subgroup of aged controls apparently does not
reflect merely sensorimotor deficits or heightened anxiety and is
most likely caused by spatial memory deficits. Amitriptyline treat-
ment significantly reduced anxiety-like measures in the aged rats,
consistent with other reports showing anxiolytic effects of anti-
depressants (Kurt et al., 2000). The effects of amitriptyline on the
affective state of the animal, together with the reduced evening
corticosterone level, may therefore contribute to the improved
cognitive function in the aged rat. Interestingly, the time spent in
the open arms of the elevated plus-maze has been shown to
correlate negatively with poststress corticosterone levels in rats
(Vallee et al., 1997). The underlying mechanism whereby chronic
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amitriptyline treatment improves anxiety in aged rats is unclear
but may be related to changes in CRH expression in the central
amygdala. Central or intra-amygdaloid administration of CRH is
anxiogenic (Dunn and Berridge, 1990), whereas the administra-
tion of CRH antagonists has anxiolytic activity (Britton et al.,
1986). Furthermore, CRH mRNA expression has been shown to
be decreased in the paraventricular nucleus of the hypothalamus
after treatment with the tricyclic antidepressant imipramine in
rats (Brady et al., 1991).
Chronically elevated glucocorticoid levels appear to cause
hippocampal-dependent memory impairments in aged rats and
humans (Seckl and Olsson, 1995; Lupien et al., 1998). Hence, the
chronically lowered plasma corticosterone levels after amitripty-
line administration may, at least in part, reduce the emergence of
cognitive impairments with aging. Other effects of amitriptyline
may also contribute to the preserved learning in the aged rats. For
example, its serotonergic actions via postsynaptic 5-HT receptors
expressed in limbic brain regions, such as the 5-HT6 receptor,
which has been implicated recently in learning and memory
(Woolley et al., 2001), may add to the positive cognitive effects.
Whether the binding density or affinity of the 5-HT6 receptors in
the hippocampus are altered by the chronic amitriptyline treat-
ment in the aged rats remains to be determined. Changes in
synaptic plasticity of hippocampal function are another possible
effect of amitriptyline. Age-related defects in spatial memory
have been associated with impaired hippocampal long-term po-
tentiation, and this can be attenuated by drugs that enhance the
cAMP signaling pathway (Bach et al., 1999). Because chronic
antidepressant treatment upregulates the cAMP cascade (Thome
et al., 2000), alterations in synaptic plasticity in the amitriptyline-
treated aged rats may also contribute to preserving cognitive
function. Although additional work is necessary to unravel the
mechanisms underlying the beneficial effects of chronic amitrip-
tyline on cognitive function with aging, perhaps long-term treat-
ment with antidepressant drugs that reduce circulating glucocor-
ticoid levels may represent a novel and potentially useful
therapeutic approach in preventing the emergence of cognitive
deficits among an aging human population.
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